{"id":"W2178569306","doi":"10.1007/s12325-015-0261-x","title":"Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease","year":2015,"lang":"en","type":"review","venue":"Advances in Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Metformin; Liraglutide; Kidney disease; Intensive care medicine; Glycemic; Diabetes mellitus; Guideline; Alogliptin; Type 2 Diabetes Mellitus; Type 2 diabetes; Saxagliptin; Internal medicine; Pharmacology; Sitagliptin; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003483098,0.0002141095,0.001078955,0.0001420467,0.00001382926,0.000006824667,0.0003275487,0.0000564411,0.00003836025],"category_scores_gemma":[0.0001246748,0.0001273924,0.00006318002,0.0004173608,0.0002205585,0.0002767202,0.0001446502,0.0001413743,0.000002624437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008989713,"about_ca_system_score_gemma":0.0004600507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000162984,"about_ca_topic_score_gemma":0.00001692597,"domain_scores_codex":[0.9986705,0.0001291456,0.0005027639,0.0003062232,0.0002142977,0.0001771321],"domain_scores_gemma":[0.998324,0.0002991129,0.0003318938,0.0009028754,0.00004377978,0.00009832608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003057906,0.0001126156,0.001798951,0.007181925,0.0002084466,0.0000034042,0.00004323611,0.000001920738,6.120425e-7,0.0002270212,0.000167686,0.9902236],"study_design_scores_gemma":[0.0009679142,0.0001507603,0.00019913,0.0154323,0.0005466361,3.369375e-7,0.000009381396,0.00004513162,9.909238e-7,0.0001173953,0.9824275,0.0001024803],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003213781,0.9981399,0.000001765459,0.0001132302,0.000121164,0.001033002,0.0001386513,0.000007583857,0.0001233943],"genre_scores_gemma":[0.0004239518,0.9982678,0.000172425,0.0001123834,0.00004687079,0.00006499967,0.0008202281,0.00002408349,0.00006728647],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9901211,"threshold_uncertainty_score":0.5194912,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1538682301300158,"score_gpt":0.4110486792444433,"score_spread":0.2571804491144275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}